To Gild the Microbe Is Anything but Wasteful
Synthetic Biology Is Enabling Optimization that Is Iterative—and Remunerative
Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients
Gene Therapy Allows Hemophilia Patients to Give Up Medication, Avoid Bleeds; but More Improvements Are Needed
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
Novel Viral Vectors for Gene Therapy
Synthetic Viral Vectors Show Promise for Mitigating Immune Response to Gene Therapy
For full access to this article login to GEN Select now.
Regenerative Medicine Looks to the Future
- After nearly a decade-long federal moratorium on embryonic stem cell research, regenerative medicine took a serious hit. Yet sometimes from adversity comes innovation. Like-minded regenerative medicine industry leaders illustrated this point at the recent “New York Stem Cell” summit. With novel cell lines involving pure pluripotent embryonic progenitors and ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.